drugset
drugset / Trial / NCT03340064

A Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age

NCT03340064 ↗

Phase 3 Completed 38 enrolled UCB Japan Co. Ltd.
NaSingle-groupOpen-labelTreatment

Summary

This is a study to confirm the efficacy of levetiracetam as adjunctive treatment or as monotherapy in pediatric epilepsy subjects aged 1 month to less than 4 years of age with partial seizures.

Timeline

Start
2017-11-30
Primary completion
2021-06-01
Completion
2023-07-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Levetiracetam Other / unclassified 42 mg/kg Oral
Subject Levetiracetam Other / unclassified 60 mg/kg Oral

Indications

focal epilepsy